Rights and permissions
About this article
Cite this article
Captopril leads to substantial cost savings in diabetic nephropathy. Pharmacoecon. Outcomes News 112, 10 (1997). https://doi.org/10.1007/BF03271609
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03271609